KHOS-240S cell

SKU:BHC11100144
Bulk Pricing
Overview
Click light‑blue chips for details

KHOS-240S cell is a cell line derived from Caucasian (Female). It is commonly used as an in vitro model for 1 research. Growth characteristics: Monolayer, adherent, Fibroblast-like. Supplied as cryopreserved cells with accompanying batch CoA and quality-control documentation.

Species Human
Disease model Osteosarcoma
Morphology Fibroblast-like
Growth Properties Monolayer, adherent
Tissue Bone
Options selector
Catalog no. Size
300433 1 cryovial
Available Options

This cell line is available in the U.S. For non-profit users, please sign and submit the Non-Profit Supply Agreement to orders@biohippo.com before placing an order. For commercial users, please complete the CLEAR Form before ordering, as additional usage fees may apply based on the intended use. For further details, please contact orders@biohippo.com. Products ship after the required agreement is completed; typical delivery is 2–3 business days. Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10^6 cells for adherent lines or 5 × 10^6 cells for suspension lines (refer to the batch CoA for details).

Field Specification
Mfr No 300433
Species Human
KHOS-240S is an osteosarcoma cell line that is derived from human bone sarcoma tissue. This cell line, along with its variants, has been extensively used in research focused on osteosarcoma, a primary malignant bone tumor that predominantly affects children and young adults. Osteosarcoma is characterized by the production of immature bone (osteoid) by malignant cells and is notorious for its aggressive behavior and potential for early metastasis, particularly to the lungs. The KHOS-240S cell line is resistant to several kinase inhibitors, including those targeting the PI3K-Akt-mTOR pathway. This resistance to common therapeutic targets makes KHOS-240S particularly valuable for studying the mechanisms of drug resistance in osteosarcoma and exploring alternative therapeutic strategies. Researchers have used this cell line to screen a variety of oncology drugs and investigational agents, which has led to the identification of compounds that could potentially overcome resistance mechanisms. The expression profile of genes associated with drug resistance and osteosarcoma biology, such as those involved in the mTOR signaling pathway, is of particular interest in studies utilizing KHOS-240S. Moreover, KHOS-240S has been utilized in the exploration of microRNA expression patterns, which may correlate with drug sensitivity or resistance. This cell line’s specific resistance to PI3K-Akt-mTOR pathway inhibitors provides an essential model for understanding how osteosarcomas may evade targeted therapies and offers a basis for the development of novel therapeutic approaches that could enhance treatment efficacy in resistant osteosarcoma subtypes.

SKU:BHC11100144

Tumorigenic: No

  • cultureMedium: EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a)
  • supplements: Supplement the medium with 10% FBS and 1% NEAA
  • dissociationReagent: Accutase
  • subculturing: Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium.
  • seedingDensity: 1 x 104 cells/cm2
  • fluidRenewal: 2 to 3 times per week
  • postThawRecovery: After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours.
  • freezeMedium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Matches this product
10% OFF
10% OFF CELL LINES-Limited-Time Offer
Ends Sep 30 CELL10
15%OFF
15% Off Cancer Antibodies
Ends Sep 30 ONCO15
$50 OFF
$50 Off All ELISA Kits
Limited time ELISA50
FREE SAMPLE
Free Sample – CellTrypase Recombinant Trypsin-Like Enzyme
Limited time offer – availa... FREESAMPLE
FREE SAMPLE
Free Sample – MycoFold™ Growth Factors
Limited time offer – availa... Request Free Sample

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today